08:11 AM EDT, 08/26/2025 (MT Newswires) -- Bausch Health Companies Inc. ( BHC ) , a global, diversified pharmaceutical company, and DURECT Corporation on Tuesday extended the expiration date of BHC's tender offer to acquire all of the outstanding shares of common stock of DURECT Corporation for US$1.75 per share in an all-cash transaction for an upfront consideration of near $63 million at closing.

A statement noted the potential for two additional net sales milestone payments of up to $350 million in the aggregate (subject to certain adjustments in respect of a retention plan) if the milestones are achieved before the earlier of the 10 year anniversary of the first commercial sale of larsucosterol in the United States and December 31, 2045.

Tuesday's statement noted the Offer has been extended until 5:00 p.m., New York City time, on September 10, 2025.